OncoTherapy Science <4564.T>-2008/09 group results

Mon May 18, 2009 1:20am EDT 

   May 18 (Reuters) -
                ONCOTHERAPY SCIENCE INC
                CONSOLIDATED FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
               Year ended      Year ended      Year to   
               Mar 31, 2009    Mar 31, 2008    Mar 31, 2010
               LATEST          YEAR-AGO        COMPANY   
               RESULTS         RESULTS         FORECASTS 
 Sales               3.33            1.97            4.45   
                (+68.7 pct)    (+145.2 pct)        (+33.7%)
 Operating        prft 27 mln    loss 385 mln    prft 248 mln
                                                  (+815.0%)
 Recurring       prft 119 mln    loss 314 mln    prft 299 mln
                                                  (+150.7%)
 Net             prft 148 mln    loss 202 mln    prft 250 mln
                                                   (+69.3%)
 EPS             prft Y739.09  loss Y1,022.51  prft Y1,240.31
 Diluted   
  EPS                 Y636.88                               
 Annual div                nil             nil             nil
  -Q4 div                  nil             nil             nil
 NOTE - OncoTherapy Science Inc engages in R&D of cancer drugs.
 For latest earnings estimates made by Toyo Keizai, please
double click on 4564.TK1.

Related Quotes and News

Company
Price
Related News
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.